retatrutide type 2 diabetes phase 2 lancet 2023 rosenstock Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Incretins: How we got here,

Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites

However, prolonged release of AMPs by engineered probiotics may kill commensal bacteria and thus may reduce their beneficial effects (Mishra et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Furman B.L

210 A study that compared the diets of 185 tinnitus patients to those of 198 matched controls without tinnitus found diets that included a wide diversity of foods, and higher consumption of high-protein foods, coffee and butter were correlated with lower risk of tinnitus

Real-world data from compounded semaglutide users shows successful weight loss maintenance across a range of doses from 0.5 to 2.4 mg, with individual factors like adherence, lifestyle changes, and genetic predisposition playing major roles